Winston Salem, NC, United States of America

David Herrington

This inventor holds 2 USPTO granted patents. Top assignee: Wake Forest University. Active years: 2009-2012.


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2009-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: David Herrington: Innovator in Genetic Research

Introduction

David Herrington is a notable inventor based in Winston Salem, NC (US). He has made significant contributions to the field of genetic research, particularly in understanding the implications of mutations in specific genes related to various diseases. With a total of 2 patents, Herrington's work has the potential to impact medical screening and treatment.

Latest Patents

Herrington's latest patents focus on the macrophage scavenger receptor 1 (MSR1) gene. His inventions disclose methods for screening subjects for an increased likelihood or risk of certain diseases or disorders. Specifically, these methods involve detecting the presence or absence of mutations in the MSR1 gene. The presence of such mutations indicates an increased risk for diseases such as prostate cancer, asthma, and cardiovascular diseases.

Career Highlights

David Herrington is affiliated with Wake Forest University, where he conducts his research and develops his inventions. His work is crucial in advancing the understanding of genetic factors that contribute to various health conditions.

Collaborations

Some of Herrington's notable coworkers include Sigun Zheng and Jianfeng Xu. Their collaborative efforts contribute to the innovative research being conducted at Wake Forest University.

Conclusion

David Herrington's contributions to genetic research and his innovative patents highlight the importance of understanding genetic mutations in disease risk. His work continues to pave the way for advancements in medical screening and treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…